Barriers and Facilitators to COVID-19 Vaccine Uptake among Polish Patients: A Qualitative Interview Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Design
2.2. Participants
2.3. Measurements
- What influenced your decision to get vaccinated?
- What made your decision to get vaccinated easier?
- Have you had any concerns about vaccination?
- Will you come for a booster immunization?
- Why do you think some people do not want to be vaccinated against COVID-19?
- What (or who) do you think would encourage/persuade people to get vaccinated against COVID-19?
2.4. Data Analysis
3. Results
3.1. Sources of Information about Vaccinations
3.1.1. Internet
3.1.2. Press and Television
3.1.3. Conversations with Friends
‘I work with a very large number of people and therefore, when discussing this topic, we learn all these different things and that’s where I get most information from’.(Interview 2)
3.1.4. Family Doctors
3.2. General Perceptions of COVID-19 Vaccinations
3.2.1. Trust in Vaccine Effectiveness
3.2.2. Vaccine-Associated Reduction in Symptom Severity
3.2.3. Trust in Scientists
3.2.4. Belief in Natural Immunity
3.3. Barriers to COVID-19 Vaccine Uptake
3.3.1. Vaccine Safety Concerns
‘Everything has been quick. And what effects will the vaccine have in 5–7 years? Will it have any long-term effects on the body? That is an unknown, right?’.(Interview 13)
3.3.2. Doubts about Vaccine Effectiveness
‘There are different things that people here say about it. They say that you sometimes get immune through overcoming natural infection and that it gives you more immunity than the vaccines’.(Interview 11)
3.3.3. Health Concerns and Fear of Vaccine Complications
‘I will state it openly that I will not have my second dose of the vaccine due to the fact that I had severe side effects following the first dose. I had very bad headaches and I had never experienced anything like that before’.(Interview 20)
3.3.4. Religious Beliefs and Other Factors
3.3.5. Disinformation and Vaccination Rumours
3.3.6. Restriction of Freedom
3.4. Facilitators to COVID-19 Vaccine Uptake
3.4.1. Determinants of COVID-19 Vaccine Acceptance
Severe Course of COVID-19
Safety of Self and Loved Ones
‘For my husband’s sake. I don’t have any underlying health conditions that increase risk of severe disease associated with COVID-19, but my husband is asthmatic. In fact, I got vaccinated because of him’.(Interview 20)
Severe Illness and Death in the Family Due to COVID-19
‘What motivated me to get vaccinated was something of a very personal nature, I think. I contracted the disease and I also lost my sister to COVID-19’.(Interview 18)
Travel Restrictions
Lack of Concern about Vaccination
3.4.2. Motivating Factors for Vaccine Uptake
Incentive Programmes
‘What would convince a Polish person? Either a legal obligation or money. In my opinion, offering money for vaccination doesn’t seem a humane or ethical thing to do. Various lottery incentives have been tried out, but they have had no effect, as you can see’.(Interview 18)
Health Concerns
Belief in Vaccine Safety
Vaccine Education
‘Definitely vaccine education, in general terms’.(Interview 18)
Vaccine Obligation
Uniformity of Vaccine Information
Voluntary Decision
4. Discussion
Strengths and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Pavia, C.S. Pasteur, vaccines, and the refusal to become fully vaccinated in the midst of the COVID-19 pandemic. Front. Public Health 2022, 10, 815816. [Google Scholar] [CrossRef]
- European Centre for Disease Prevention and Control. Vaccine Hesitancy. Available online: https://www.ecdc.europa.eu/en/immunisation-vaccines/vaccine-hesitancy (accessed on 12 August 2022).
- European Centre for Disease Prevention and Control. Facilitating COVID-19 Vaccination Acceptance and Uptake in the EU/EEA; ECDC: Stockholm, Sweden, 2021. [Google Scholar]
- Polish Press Agency. Poland Launches Lottery to Promote COVID-19 Vaccinations. 2021. Available online: https://www.pap.pl/en/news/news%2C902316%2Cpoland-launches-lottery-promote-covid-19-vaccinations.html (accessed on 12 August 2022).
- Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 2020, 27, 225–228. [Google Scholar] [CrossRef]
- De Figueiredo, A.; Larson, H.J. Exploratory study of the global intent to accept COVID-19 vaccinations. Commun. Med. 2021, 1, 30. [Google Scholar] [CrossRef]
- Fojnica, A.; Osmanovic, A.; Đuzic, N.; Fejzic, A.; Mekic, E.; Gromilic, Z.; Muhovic, I.; Kurtovic-Kozaric, A. COVID-19 vaccine acceptance and rejection in an adult population in Bosnia and Herzegovina. PLoS ONE 2022, 17, e0264754. [Google Scholar] [CrossRef]
- Hamilton, E.M.; Oversby, S.; Ratsch, A.; Kitchener, S. COVID-19 Vaccination: An Exploratory Study of the Motivations and Concerns Detailed in the Medical Records of a Regional Australian Population. Vaccines 2022, 10, 657. [Google Scholar] [CrossRef]
- Our World in Data. Coronavirus (COVID-19) Vaccinations. Available online: https://ourworldindata.org/covid-vaccinations?country (accessed on 12 August 2022).
- Schwarzinger, M.; Watson, V.; Arwidson, P.; Alla, F.; Luchini, S. COVID-19 vaccine hesitancy in a representative working-age population in France: A survey experiment based on vaccine characteristics. Lancet Public Health 2021, 6, e210–e221. [Google Scholar] [CrossRef]
- Chen, H.; Li, X.; Gao, J.; Liu, X.; Mao, Y.; Wang, R.; Zheng, P.; Xiao, Q.; Jia, Y.; Fu, H.; et al. Health Belief Model Perspective on the Control of COVID-19 Vaccine Hesitancy and the Promotion of Vaccination in China: Web-Based Cross-sectional Study. J. Med. Internet Res. 2021, 23, e29329. [Google Scholar] [CrossRef]
- Wong, L.P.; Alias, H.; Danaee, M.; Ahmed, J.; Lachyan, A.; Cai, C.Z.; Lin, Y.; Hu, Z.; Tan, S.Y.; Lu, Y.; et al. COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: A global survey of 17 countries. Infect. Dis. Poverty 2021, 10, 122. [Google Scholar] [CrossRef]
- Babicki, M.; Malchrzak, W.; Mastalerz-Migas, A. Assessment of Attitudes, Main Concerns and Sources of Knowledge Regarding COVID-19 Vaccination in Poland in the Unvaccinated Individuals-A Nationwide Survey. Vaccines 2022, 10, 381. [Google Scholar] [CrossRef]
- Lin, C.; Parker, T.; Pejavara, K.; Smith, D.; Tu, R.; Tu, P. “I Would Never Push a Vaccine on You”: A Qualitative Study of Social Norms and Pressure in Vaccine Behavior in the U.S. Vaccines 2022, 10, 1402. [Google Scholar] [CrossRef]
- Bateman, L.B.; Hall, A.G.; Anderson, W.A.; Cherrington, A.L.; Helova, A.; Judd, S.; Kimberly, R.; Oates, G.R.; Osborne, T.; Ott, C.; et al. Exploring COVID-19 Vaccine Hesitancy among Stakeholders in African American and Latinx Communities in the Deep South through the Lens of the Health Belief Model. Am. J. Health Promot. 2022, 36, 288–295. [Google Scholar] [CrossRef]
- Denford, S.; Mowbray, F.; Towler, L.; Wehling, H.; Lasseter, G.; Amlôt, R.; Oliver, I.; Yardley, L.; Hickman, M. Exploration of attitudes regarding uptake of COVID-19 vaccines among vaccine hesitant adults in the UK: A qualitative analysis. BMC Infect. Dis. 2022, 22, 407. [Google Scholar] [CrossRef]
- Patton, M.Q. Qualitative Research & Evaluation Methods, 3rd ed.; Sage Publications: Thousand Oaks, CA, USA; London, UK; New Delhi, India, 2002. [Google Scholar]
- Saunders, B.; Sim, J.; Kingstone, T.; Baker, S.; Waterfield, J.; Bartlam, B.; Burroughs, H.; Jinks, C. Saturation in qualitative research: Exploring its conceptualization and operationalization. Qual. Quant. 2018, 52, 1893–1907. [Google Scholar] [CrossRef]
- Kiger, M.E.; Varpio, L. Thematic analysis of qualitative data: AMEE Guide No. 131. Med. Teach. 2020, 42, 846–854. [Google Scholar] [CrossRef]
- Tong, A.; Sainsbury, P.; Craig, J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int. J. Qual. Health Care 2007, 19, 349–357. [Google Scholar] [CrossRef] [Green Version]
- Afrifa-Anane, G.F.; Larbi, R.T.; Addo, B.; Agyekum, M.W.; Kyei-Arthur, F.; Appiah, M.; Agyemang, C.O.; Sakada, I.G. Facilitators and barriers to COVID-19 vaccine uptake among women in two regions of Ghana: A qualitative study. PLoS ONE 2022, 17, e0272876. [Google Scholar] [CrossRef]
- Lockyer, B.; Islam, S.; Rahman, A.; Dickerson, J.; Pickett, K.; Sheldon, T.; Wright, J.; McEachan, R.; Sheard, L. Understanding COVID-19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving citizens in Bradford, UK. Health Expect. 2021, 24, 1158–1167. [Google Scholar] [CrossRef]
- Osakwe, Z.T.; Osborne, J.C.; Osakwe, N.; Stefancic, A. Facilitators of COVID-19 vaccine acceptance among Black and Hispanic individuals in New York: A qualitative study. Am. J. Infect. Control 2022, 50, 268–272. [Google Scholar] [CrossRef]
- Domosławska-Żylińska, K.; Krysińska-Pisarek, M.; Czabanowska, K.; Sesa, G. Vaccinated and Unvaccinated Risk Perceptions and Motivations for COVID-19 Preventive Measures Based on EPPM-A Polish Qualitative Pilot Study. Int. J. Environ. Res. Public Health 2022, 19, 13473. [Google Scholar] [CrossRef]
- Steinert, J.I.; Sternberg, H.; Prince, H.; Fasolo, B.; Galizzi, M.M.; Büthe, T.; Veltri, G.A. COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity. Sci. Adv. 2022, 8, eabm9825. [Google Scholar] [CrossRef]
- Reno, C.; Maietti, E.; Fantini, M.P.; Savoia, E.; Manzoli, L.; Montalti, M.; Gori, D. Enhancing COVID-19 vaccines acceptance: Results from a survey on vaccine hesitancy in Northern Italy. Vaccines 2021, 9, 378. [Google Scholar] [CrossRef]
- Freeman, D.; Loe, B.S.; Yu, L.M.; Freeman, J.; Chadwick, A.; Vaccari, C.; Shanyinde, M.; Harris, V.; Waite, F.; Rosebrock, L.; et al. Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): A single-blind, parallel-group, randomised controlled trial. Lancet Public Health 2021, 6, e416–e427. [Google Scholar] [CrossRef]
- Soares, P.; Rocha, J.V.; Moniz, M.; Gama, A.; Laires, P.A.; Pedro, A.R.; Dias, S.; Leite, A.; Nunes, C. Factors Associated with COVID-19 Vaccine Hesitancy. Vaccines 2021, 9, 300. [Google Scholar] [CrossRef]
- Nakhostin-Ansari, A.; Zimet, G.D.; Khonji, M.S.; Aghajani, F.; Teymourzadeh, A.; Rastegar Kazerooni, A.A.; Pirayandeh, P.; Aghajani, R.; Safari, S.; Khalaj, K.; et al. Acceptance or Rejection of the COVID-19 Vaccine: A Study on Iranian People’s Opinions toward the COVID-19 Vaccine. Vaccines 2022, 10, 670. [Google Scholar] [CrossRef]
- Loomba, S.; de Figueiredo, A.; Piatek, S.J.; de Graaf, K.; Larson, H.J. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat. Hum. Behav. 2021, 5, 337–348. [Google Scholar] [CrossRef]
- Fan, K.S.; Ghani, S.A.; Machairas, N.; Lenti, L.; Fan, K.H.; Richardson, D.; Scott, A.; Raptis, D.A. COVID-19 prevention and treatment information on the internet: A systematic analysis and quality assessment. BMJ Open 2020, 10, e040487. [Google Scholar] [CrossRef]
- Rzymski, P.; Borkowski, L.; Drąg, M.; Flisiak, R.; Jemielity, J.; Krajewski, J.; Mastalerz-Migas, A.; Matyja, A.; Pyrć, K.; Simon, K. The strategies to support the COVID-19 vaccination with evidence-based communication and tackling misinformation. Vaccines 2021, 9, 109. [Google Scholar] [CrossRef] [PubMed]
- Olagoke, A.A.; Olagoke, O.O.; Hughes, A.M. Intention to Vaccinate Against the Novel 2019 Coronavirus Disease: The Role of Health Locus of Control and Religiosity. J. Relig. Health 2021, 60, 65–80. [Google Scholar] [CrossRef] [PubMed]
- Orlandi, L.B.; Febo, V.; Perdichizzi, S. The role of religiosity in product and technology acceptance: Evidence from COVID-19 vaccines. Technol. Forecast. Soc. Chang. 2022, 185, 122032. [Google Scholar] [CrossRef] [PubMed]
- Harapan, H.; Wagner, A.L.; Yufika, A.; Winardi, W.; Anwar, S.; Gan, A.K.; Setiawan, A.M.; Rajamoorthy, Y.; Sofyan, H.; Mudatsir, M. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Front. Public Health 2020, 8, 381. [Google Scholar] [CrossRef] [PubMed]
- Verger, P.; Botelho-Nevers, E.; Garrison, A.; Gagnon, D.; Gagneur, A.; Gagneux-Brunon, A.; Dubé, E. Vaccine hesitancy in health-care providers in Western countries: A narrative review. Expert Rev. Vaccines 2022, 21, 909–927. [Google Scholar] [CrossRef]
- World Health Organization. Conducting Community Engagement for COVID-19 Vaccines. Available online: https://apps.who.int/iris/rest/bitstreams/1332503/retrieve (accessed on 16 December 2022).
- Corpuz, J.C.G. Multisectoral Approach on COVID-19 vaccination: A proposed solution on vaccine hesitancy. J. Public Health 2021, 43, e370–e371. [Google Scholar] [CrossRef] [PubMed]
- Lazarus, J.V.; Wyka, K.; Rauh, L.; Rabin, K.; Ratzan, S.; Gostin, L.O.; Larson, H.J.; El-Mohandes, A. Hesitant or Not? The Association of Age, Gender, and Education with Potential Acceptance of a COVID-19 Vaccine: A Country-level Analysis. J. Health Commun. 2020, 25, 799–807. [Google Scholar] [CrossRef] [PubMed]
- Raciborski, F.; Jankowski, M.; Gujski, M.; Pinkas, J.; Samel-Kowalik, P. Changes in Attitudes towards the COVID-19 Vaccine and the Willingness to Get Vaccinated among Adults in Poland: Analysis of Serial, Cross-Sectional, Representative Surveys, January–April 2021. Vaccines 2021, 9, 832. [Google Scholar] [CrossRef] [PubMed]
- Wang, Q.; Hu, S.; Du, F.; Zang, S.; Xing, Y.; Qu, Z.; Zhang, X.; Lin, L.; Hou, Z. Mapping global acceptance and uptake of COVID-19 vaccination: A systematic review and meta-analysis. Commun. Med. 2022, 2, 113. [Google Scholar] [CrossRef] [PubMed]
- Lindner-Pawłowicz, K.; Mydlikowska-Śmigórska, A.; Łampika, K.; Sobieszczańska, M. COVID-19 Vaccination Acceptance among Healthcare Workers and General Population at the Very Beginning of the National Vaccination Program in Poland: A Cross-Sectional, Exploratory Study. Vaccines 2021, 10, 66. [Google Scholar] [CrossRef] [PubMed]
- Kricorian, K.; Civen, R.; Equils, O. COVID-19 vaccine hesitancy: Misinformation and perceptions of vaccine safety. Hum. Vaccines Immunother. 2022, 18, 1950504. [Google Scholar] [CrossRef]
- Dubé, E.; Gagnon, D.; Vivion, M. Optimizing communication material to address vaccine hesitancy. Can. Commun. Dis. Rep. 2020, 46, 48–52. [Google Scholar] [CrossRef]
- Nuwarda, R.F.; Ramzan, I.; Weekes, L.; Kayser, V. Vaccine Hesitancy: Contemporary Issues and Historical Background. Vaccines 2022, 10, 1595. [Google Scholar] [CrossRef]
- The Lancet Infectious Diseases. The COVID-19 infodemic. Lancet Infect. Dis. 2020, 20, 875. [Google Scholar] [CrossRef]
- Magee, L.; Knights, F.; Mckechnie, D.G.J.; Al-Bedaery, R.; Razai, M.S. Facilitators and barriers to COVID-19 vaccination uptake among ethnic minorities: A qualitative study in primary care. PLoS ONE 2022, 17, e0270504. [Google Scholar] [CrossRef] [PubMed]
- Tesfaw, A.; Arage, G.; Teshome, F.; Taklual, W.; Seid, T.; Belay, E.; Mehiret, G. Community risk perception and barriers for the practice of COVID-19 prevention measures in Northwest Ethiopia: A qualitative study. PLoS ONE 2021, 16, e0257897. [Google Scholar] [CrossRef] [PubMed]
Characteristics | N (%) |
---|---|
Gender | |
Female | 8 (36.4) |
Male | 14 (63.6) |
Age | |
38–40 | 2 (9.2%) |
41–50 | 3 (13.6%) |
51–60 | 7 (31.8%) |
61–70 | 7 (31.8%) |
≥71 | 3 (13.6%) |
Education | |
Primary | 3 (13.6%) |
Technical/Vocational | 4 (18.2%) |
Secondary | 7 (31.8%) |
Higher | 8 (36.4%) |
Time since hospitalization (in months) | |
3–6 | 4 (18.2) |
7–12 | 9 (40.9) |
13–18 | 8 (36.4) |
19–24 | 1 (4.5) |
Number of COVID-19 vaccine doses of taken | |
1 dose, no intention to take another dose | 3 (13.6) |
2 doses, intention to take a 3rd dose | 4 (18.2) |
2 doses, undecided about a 3rd dose | 1 (4.5) |
3 doses | 9 (40.9) |
none | 5 (22.8) |
Category | Sub-Categories |
---|---|
Barriers to COVID-19 vaccine uptake | Vaccine safety concerns |
Doubts about vaccine effectiveness | |
Health concerns and fear of vaccine complications | |
Religious beliefs and other factors | |
Disinformation and vaccination rumours | |
Restriction of freedom |
Category | Sub-Categories |
---|---|
Determinants of COVID-19 vaccine acceptance | Severe course of COVID-19 |
Safety of self and loved ones | |
Severe illness and death in the family due to COVID-19 | |
Travel restrictions | |
Lack of concern about vaccination | |
Motivating factors for vaccine uptake | Incentive programmes |
Health concerns | |
Belief in vaccine safety | |
Vaccine education | |
Vaccination obligation | |
Uniformity of vaccine information | |
Voluntary decision |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Marcinowicz, L.; Fejfer-Wirbal, E.; Dudzik, A.; Genowska, A.; Terlikowski, S. Barriers and Facilitators to COVID-19 Vaccine Uptake among Polish Patients: A Qualitative Interview Study. Vaccines 2023, 11, 177. https://doi.org/10.3390/vaccines11010177
Marcinowicz L, Fejfer-Wirbal E, Dudzik A, Genowska A, Terlikowski S. Barriers and Facilitators to COVID-19 Vaccine Uptake among Polish Patients: A Qualitative Interview Study. Vaccines. 2023; 11(1):177. https://doi.org/10.3390/vaccines11010177
Chicago/Turabian StyleMarcinowicz, Ludmiła, Ewa Fejfer-Wirbal, Agnieszka Dudzik, Agnieszka Genowska, and Sławomir Terlikowski. 2023. "Barriers and Facilitators to COVID-19 Vaccine Uptake among Polish Patients: A Qualitative Interview Study" Vaccines 11, no. 1: 177. https://doi.org/10.3390/vaccines11010177
APA StyleMarcinowicz, L., Fejfer-Wirbal, E., Dudzik, A., Genowska, A., & Terlikowski, S. (2023). Barriers and Facilitators to COVID-19 Vaccine Uptake among Polish Patients: A Qualitative Interview Study. Vaccines, 11(1), 177. https://doi.org/10.3390/vaccines11010177